Berberine Alleviates Hepatic Steatosis by Restoring CPT1α Histone Acetylation and Modulating HDAC2/SIRT2

Area of Science:

• Biochemistry
• Molecular Biology
• Nutritional Science

Background:

• High-fat diet (HFD) causes hepatic steatosis, impairing mitochondrial fatty acid oxidation.
• Carnitine palmitoyltransferase 1α (CPT1α) is crucial for fatty acid metabolism, but its regulation in HFD-induced steatosis is unclear.
• Chromatin mechanisms governing Cpt1a expression in diet-induced fatty liver disease require further definition.

Purpose of the Study:

• Map histone modifications at the hepatic Cpt1a locus.
• Investigate if berberine (BBR) restores Cpt1a transcription via histone acetylation remodeling.

Main Methods:

• Rats were fed normal diet (ND), HFD, or BBR+HFD.
• ChIP-qPCR analyzed histone modifications at the Cpt1a locus in liver samples.
• In vitro studies used TSA and SAHA to assess HDAC-sensitive Cpt1a regulation.

Main Results:

• HFD decreased H3/H4 acetylation and increased H3K9 methylation at Cpt1a regulatory regions.
• BBR restored H3/H4 acetylation and reduced H3K9me3, while decreasing HDAC2 and SIRT2 mRNA levels.
• TSA and SAHA treatments significantly increased Cpt1a mRNA levels.

Conclusions:

• Berberine alleviates HFD-induced hepatic steatosis by restoring Cpt1a histone acetylation.
• Modulation of HDAC2/SIRT2 by BBR suggests a chromatin-based mechanism in fatty liver disease.
• Further functional studies are needed to validate the proposed HDAC2/SIRT2-linked pathway.